| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ABSORB IV: will the low rate of scaffold thrombosis persist?
|
Tijssen, Ruben Y G
|
|
2019
|
393 |
10189 |
p. 2392
|
artikel
|
| 2 |
ABSORB IV: will the low rate of scaffold thrombosis persist? – Authors' reply
|
Stone, Gregg W
|
|
2019
|
393 |
10189 |
p. 2392-2393
|
artikel
|
| 3 |
A coming of age for gender in global health
|
Clark, Jocalyn
|
|
2019
|
393 |
10189 |
p. 2367-2369
|
artikel
|
| 4 |
Alcohol and the global burden of disease
|
Di Castelnuovo, Augusto F
|
|
2019
|
393 |
10189 |
p. 2389
|
artikel
|
| 5 |
Alcohol and the global burden of disease
|
Shield, Kevin D
|
|
2019
|
393 |
10189 |
p. 2390
|
artikel
|
| 6 |
Alcohol and the global burden of disease
|
Abat, Cedric
|
|
2019
|
393 |
10189 |
p. 2390-2391
|
artikel
|
| 7 |
Alcohol and the global burden of disease
|
Astrup, Arne
|
|
2019
|
393 |
10189 |
p. 2390
|
artikel
|
| 8 |
Alcohol and the global burden of disease – Authors' reply
|
Griswold, Max
|
|
2019
|
393 |
10189 |
p. 2391-2392
|
artikel
|
| 9 |
Alcohol policy in the UK: where next?
|
Gilmore, Ian
|
|
2019
|
393 |
10189 |
p. 2377-2378
|
artikel
|
| 10 |
A new normal: addressing gender to improve health
|
Gates, Melinda
|
|
2019
|
393 |
10189 |
p. 2373-2374
|
artikel
|
| 11 |
Antibiotics for operative vaginal delivery: practice-changing data
|
Berghella, Vincenzo
|
|
2019
|
393 |
10189 |
p. 2361-2362
|
artikel
|
| 12 |
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial
|
Rini, Brian I
|
|
2019
|
393 |
10189 |
p. 2404-2415
|
artikel
|
| 13 |
Burosumab treatment of children with X-linked hypophosphataemic rickets
|
Gordon, Rebecca J
|
|
2019
|
393 |
10189 |
p. 2364-2366
|
artikel
|
| 14 |
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
|
Imel, Erik A
|
|
2019
|
393 |
10189 |
p. 2416-2427
|
artikel
|
| 15 |
Department of Error
|
|
|
2019
|
393 |
10189 |
p. 2394
|
artikel
|
| 16 |
Department of Error
|
|
|
2019
|
393 |
10189 |
p. 2394
|
artikel
|
| 17 |
Department of Error
|
|
|
2019
|
393 |
10189 |
p. 2394
|
artikel
|
| 18 |
Department of Error
|
|
|
2019
|
393 |
10189 |
p. 2394
|
artikel
|
| 19 |
Doing gender better: can the UN step up?
|
Allotey, Pascale
|
|
2019
|
393 |
10189 |
p. 2371-2373
|
artikel
|
| 20 |
Durable complete response in renal cell carcinoma clinical trials
|
Pilié, Patrick G
|
|
2019
|
393 |
10189 |
p. 2362-2364
|
artikel
|
| 21 |
Dyspnoea in the GLOBAL LEADERS trial
|
Martí, David
|
|
2019
|
393 |
10189 |
p. 2393
|
artikel
|
| 22 |
Dyspnoea in the GLOBAL LEADERS trial – Authors' reply
|
Jüni, Peter
|
|
2019
|
393 |
10189 |
p. 2393-2394
|
artikel
|
| 23 |
Gender equality and health: laying the foundations for change
|
George, Asha S
|
|
2019
|
393 |
10189 |
p. 2369-2371
|
artikel
|
| 24 |
Gender equality: engaging men in change
|
Flood, Michael
|
|
2019
|
393 |
10189 |
p. 2386-2387
|
artikel
|
| 25 |
Gender inequality and restrictive gender norms: framing the challenges to health
|
Heise, Lori
|
|
2019
|
393 |
10189 |
p. 2440-2454
|
artikel
|
| 26 |
Gender norms and health: insights from global survey data
|
Weber, Ann M
|
|
2019
|
393 |
10189 |
p. 2455-2468
|
artikel
|
| 27 |
Health targeted in Sudan's political transition
|
Devi, Sharmila
|
|
2019
|
393 |
10189 |
p. 2380
|
artikel
|
| 28 |
How can we avoid making universal health coverage a white elephant?
|
Jimba, Masamine
|
|
2019
|
393 |
10189 |
p. 2394
|
artikel
|
| 29 |
Isolated cardiac cysticercosis: treatment with or without steroids?
|
Kalra, Dinesh K
|
|
2019
|
393 |
10189 |
p. 2439
|
artikel
|
| 30 |
John Lennard-Jones
|
Watts, Geoff
|
|
2019
|
393 |
10189 |
p. 2388
|
artikel
|
| 31 |
Making women equally visible
|
McCartney, Margaret
|
|
2019
|
393 |
10189 |
p. 2383-2384
|
artikel
|
| 32 |
Offline: A Chief Medical Officer—unplugged
|
Horton, Richard
|
|
2019
|
393 |
10189 |
p. 2379
|
artikel
|
| 33 |
Ongoing pregnancy as the primary outcome for the inSIGHT study
|
Smit, Janine G
|
|
2019
|
393 |
10189 |
p. 2389
|
artikel
|
| 34 |
Pharma blockchains AI for drug development
|
Burki, Talha
|
|
2019
|
393 |
10189 |
p. 2382
|
artikel
|
| 35 |
Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial
|
Knight, Marian
|
|
2019
|
393 |
10189 |
p. 2395-2403
|
artikel
|
| 36 |
Recognising physicians with impairment
|
The Lancet,
|
|
2019
|
393 |
10189 |
p. 2360
|
artikel
|
| 37 |
Reducing the global burden of depression: a Lancet–World Psychiatric Association Commission
|
Herrman, Helen
|
|
2019
|
393 |
10189 |
p. e42-e43
|
artikel
|
| 38 |
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|
Rodger, Alison J
|
|
2019
|
393 |
10189 |
p. 2428-2438
|
artikel
|
| 39 |
Sarah Hawkes: shining a gender lens on global health
|
Lane, Richard
|
|
2019
|
393 |
10189 |
p. 2385
|
artikel
|
| 40 |
Successful treatment of HIV eliminates sexual transmission
|
Cohen, Myron S
|
|
2019
|
393 |
10189 |
p. 2366-2367
|
artikel
|
| 41 |
The devastating impact of Trump's global gag rule
|
The Lancet,
|
|
2019
|
393 |
10189 |
p. 2359
|
artikel
|
| 42 |
Trump administration limits fetal tissue research
|
Jaffe, Susan
|
|
2019
|
393 |
10189 |
p. 2381
|
artikel
|
| 43 |
Venezuela: food and medicines used as weapons
|
The Lancet,
|
|
2019
|
393 |
10189 |
p. 2360
|
artikel
|
| 44 |
Why now for a Series on gender equality, norms, and health?
|
Darmstadt, Gary L
|
|
2019
|
393 |
10189 |
p. 2374-2377
|
artikel
|
Tijdschrift beschrijving